Cas:73069-25-7 Praeruptorin A manufacturer & supplier

We serve Chemical Name:Praeruptorin A CAS:73069-25-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Praeruptorin A

Chemical Name:Praeruptorin A
CAS.NO:73069-25-7
Synonyms:PraeruptorinA;2-Butenoicacid,2-methyl-,(9S,10S)-10-(acetyloxy);(+)-cis-4′-acetyl-3′-angeloylkhellactone;9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H;2-Butenoic acid, 2-methyl-, (9R,10S)-10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b’]dipyran-9-yl ester, (2Z)-;(9S,10S)-10-Acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl (2Z)-2-methylbut-2-enoate;(+)-Praeruptorin;(+)-cis-3′-angeloyl-4′-acetylkhellactone;2-Butenoic acid, 2-methyl-, (9S,10S)-10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b’]dipyran-9-yl ester, (2Z)-;(-)-pareruptorin A;(9R,10S)-10-Acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl (2Z)-2-methyl-2-butenoate;(+)-isopteryxin;(9S,10S)-10-Acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl (2Z)-2-methyl-2-butenoate
Molecular Formula:C21H22O7
Molecular Weight:386.395
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:486.8±45.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.574
PSA:92.04000
Exact Mass:386.136566
LogP:4.18

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like PraeruptorinA chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(9S,10S)-10-Acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl (2Z)-2-methyl-2-butenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(+)-cis-3′-angeloyl-4′-acetylkhellactone Use and application,(+)-Praeruptorin technical grade,usp/ep/jp grade.


Related News: ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. 3-Amino-10-hydroxy-campher manufacturers Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. 2,2′,2′,2”-(4-diethylamino-pyrimido[5,4-d]pyrimidine-2,6-diylbisazanediyl)-tetrakis-ethanol suppliers In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. N-p-ethyl-carbobenzoxy-L-tryptophane vendor & factory.